- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
600671
SHH
Week ended 07 Aug 2026
Weekly Investor Report
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd · Healthcare · Drug Manufacturers - General
Latest close
21.53 CNY
6.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 10.1% above the Trend Line and sits at 78.9% of its 52-week range. The latest completed week returned 6.1%, after a 12.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
70
out of 100
Latest Close
21.53 CNY
7 Aug 2026
1W Return
6.1%
latest completed week
4W Return
12.1%
short-term follow-through
12W Return
14.1%
quarterly tape
Trend Breadth
78.8%
41 of 52 weeks active
Volume Ratio
1.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
6.1%
Latest completed week; four-week move 12.1%.
Indicator stack
43/79
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 56.67%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 10.1% above the Trend Line and sits at 78.9% of its 52-week range. The latest completed week returned 6.1%, after a 12.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3612-week average 0.35
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.36Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.1% over four weeks, 14.1% over 12 weeks, and 40.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year41
Trend breadth78.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.72Latest activity-pressure read.
Pressure change200.7%Four-week change in activity pressure.
Leadership15.00Latest relative-leadership reading.
RS change354.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.1%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+9.0%Week of 19 Jun.
Worst week-7.7%Week of 29 May.
Latest week+6.1%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains6
Flat weeks0
Modest losses6
Sharp losses6
Recent vol6.0%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Drug Manufacturers - General
4-week rank3 / 22
Group average3.7%
Trend breadth9.1%
Trend9.1%active weekly trend signals
MD40.9%positive activity pressure
RS18.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape66/100
Trend, activity pressure, participation, and risk combine to a 66/100 tape read.
Indicator analysis30/100Latest 12-week confirmation: trend 1/12, activity pressure 3/12, relative leadership 6/12.
Activity pressure 0.36; 1 reversal markers Next-Week ExpectancyPositive 56.67%Next-week expectancy is positive with a 56.67% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 21.53 CNY | 6.1% | 19.55 CNY | 12.82 CNY | 0.72 | 15.00 | 26.8M | Off |
| 31 Jul 2026 | 20.30 CNY | 5.0% | 19.41 CNY | 12.74 CNY | 0.51 | 12.00 | 18.7M | Off |
| 24 Jul 2026 | 19.33 CNY | -6.9% | 19.30 CNY | 12.66 CNY | 0.12 | 7.69 | 33.3M | Off |
| 17 Jul 2026 | 20.77 CNY | 8.1% | 19.24 CNY | 12.59 CNY | -0.33 | 17.76 | 47.8M | Off |
| 10 Jul 2026 | 19.21 CNY | 4.1% | 19.10 CNY | 12.51 CNY | -0.71 | 3.30 | 19.6M | Off |
| 3 Jul 2026 | 18.46 CNY | 7.8% | 19.04 CNY | 12.43 CNY | -1.11 | -1.52 | 4.7M | Off |
| 26 Jun 2026 | 17.12 CNY | -4.7% | 19.00 CNY | 12.36 CNY | -1.22 | -8.07 | 3.7M | Off |
| 19 Jun 2026 | 17.96 CNY | 9.0% | 18.98 CNY | 12.30 CNY | -1.25 | -4.87 | 12.9M | Off |
| 12 Jun 2026 | 16.47 CNY | -2.8% | 19.01 CNY | 12.23 CNY | -1.34 | -11.30 | 1.8M | Off |
| 5 Jun 2026 | 16.94 CNY | -3.0% | 19.09 CNY | 12.18 CNY | -1.27 | -8.66 | 1.8M | Off |
| 29 May 2026 | 17.46 CNY | -7.7% | 19.16 CNY | 12.12 CNY | -1.12 | -6.66 | 9.3M | Off |
| 22 May 2026 | 18.92 CNY | 0.3% | 19.22 CNY | 12.05 CNY | -0.95 | 0.30 | 9.7M | On |
| 15 May 2026 | 18.87 CNY | -6.0% | 19.20 CNY | 11.98 CNY | -0.84 | -0.26 | 9.1M | On |
| 8 May 2026 | 20.08 CNY | 0.9% | 19.21 CNY | 11.91 CNY | -0.60 | 5.24 | 7.2M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.